Steward Partners Investment Advisory, LLC - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 310 filers reported holding CRISPR THERAPEUTICS AG in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.

Quarter-by-quarter ownership
Steward Partners Investment Advisory, LLC ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$90,054
-17.9%
1,984
+1.6%
0.00%
-50.0%
Q2 2023$109,641
+21.9%
1,953
-1.8%
0.00%
+100.0%
Q1 2023$89,917
+10.2%
1,988
-1.0%
0.00%0.0%
Q4 2022$81,625
-34.7%
2,008
+5.0%
0.00%
-50.0%
Q3 2022$125,000
+5.9%
1,913
-1.6%
0.00%0.0%
Q2 2022$118,000
+4.4%
1,944
+8.2%
0.00%0.0%
Q1 2022$113,000
+113.2%
1,796
+155.5%
0.00%
+100.0%
Q4 2021$53,000
-55.1%
703
-33.1%
0.00%
-50.0%
Q3 2021$118,000
-58.9%
1,051
-40.6%
0.00%
-60.0%
Q2 2021$287,000
-100.0%
1,770
-78.7%
0.01%
-44.4%
Q1 2021$1,012,330,000
+722992.9%
8,308
+806.0%
0.01%
+200.0%
Q4 2020$140,000
+351.6%
917
+145.8%
0.00%
+200.0%
Q3 2020$31,000
+40.9%
373
+24.3%
0.00%0.0%
Q2 2020$22,000
+83.3%
3000.0%0.00%
Q1 2020$12,000
-33.3%
3000.0%0.00%
-100.0%
Q4 2019$18,000
+50.0%
3000.0%0.00%
Q3 2019$12,000
-14.3%
3000.0%0.00%
-100.0%
Q2 2019$14,000
+7.7%
3000.0%0.00%0.0%
Q3 2018$13,000
+116.7%
300
+200.0%
0.00%
Q2 2018$6,000
+50.0%
1000.0%0.00%
Q1 2018$4,0001000.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q3 2020
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$31,294,00031.24%
NEA Management Company, LLC 1,590,002$365,593,00010.56%
Ariose Capital Management Ltd 37,900$2,379,0009.30%
ARK Investment Management 9,404,071$590,294,0002.46%
NIA IMPACT ADVISORS, LLC 80,082$5,027,0002.44%
Nikko Asset Management Americas, Inc. 4,619,747$291,044,0002.14%
PLUSTICK MANAGEMENT LLC 50,000$3,139,0001.98%
Integral Health Asset Management, LLC 120,000$7,532,0001.96%
Valiant Capital Management, L.P. 240,683$15,108,0001.73%
Deuterium Capital Management, LLC 18,000$1,130,0001.45%
View complete list of CRISPR THERAPEUTICS AG shareholders